Presence of cancer cells in healthy individuals
Pro Research Analysisby 
Searched over 200M research papers
Circulating Tumor Cells and Cancer Cell Presence in Healthy Individuals
Research shows that cancer cells, or cells with cancer-like properties, can sometimes be detected in individuals who appear healthy and have no cancer diagnosis. Screening studies using blood tests have found that a small percentage of healthy or high-risk individuals have circulating tumor cells (CTCs) in their blood, which are typically associated with cancer spread. For example, in a study of 3,388 high-risk but subjectively healthy people, about 3% had detectable CTCs, suggesting that these cells can be present before any clinical symptoms of cancer appear . Another large study found that 3.6% of asymptomatic individuals had circulating ensembles of tumor-associated cells (C-ETACs), and those with detectable C-ETACs had a much higher risk—230 times greater—of developing cancer within a year compared to those without . These findings indicate that the presence of such cells in healthy individuals is rare but significant for cancer risk prediction Castro2018Ranade2020.
Cell-Free DNA and Its Origin in Healthy and Cancer Patients
Cell-free DNA (cfDNA) is another marker used to detect cancer. Studies have shown that cfDNA levels are often higher in cancer patients, but the majority of cfDNA in both healthy individuals and cancer patients comes from normal blood cells, especially leukocytes, rather than from cancer cells themselves . In early-stage cancer, there is a notable increase in cfDNA, but much of this increase originates from healthy tissue, not the tumor, possibly due to systemic effects of cancer on the body’s cell turnover or DNA clearance mechanisms Mamis2026Mattox2023. This means that while cfDNA can be a useful marker, its presence and increase are not always directly linked to cancer cells themselves.
Clonal Expansion and Cancer-Associated Mutations in Normal Tissues
Recent research has revealed that normal, healthy tissues can contain clones of cells with mutations commonly associated with cancer. These clonal expansions are especially common with aging or after exposure to environmental stressors. While these mutated clones share features with cancer cells, their presence does not always lead to cancer. In fact, some mutations are more common in normal tissue than in cancer, suggesting that not all mutated clones progress to malignancy . This highlights that the presence of cancer-associated genetic changes in healthy individuals is not unusual and does not always indicate disease.
Differences Between Cancer Cells and Healthy Cells
Cancer cells differ from healthy cells in several ways, including gene expression and physical properties. Studies comparing blood samples from cancer patients and healthy individuals have found that certain gene sets are expressed at much higher levels in cancer samples . Additionally, cancer cells are often physically softer and more deformable than normal cells, a property that can sometimes be used for diagnostic purposes . However, these differences are not always absolute, and some overlap can occur.
Detection Challenges and Diagnostic Implications
Detecting rare cancer cells in the blood of healthy individuals is technically challenging due to the overwhelming presence of normal blood cells. New methods, such as using specific proteins or gene expression assays, are being developed to improve sensitivity and specificity for early cancer detection . The presence of cancer cells or cancer-like mutations in healthy people suggests that early detection and monitoring could be possible, but also that not every detection will lead to cancer.
Conclusion
In summary, cancer cells or cells with cancer-like mutations can sometimes be found in healthy individuals, especially those at higher risk or older age. Their presence is rare but can indicate a higher risk of developing cancer in the future. Most cell-free DNA in blood comes from normal cells, even in cancer patients, and clonal expansions with cancer-associated mutations are common in normal tissues. These findings are shaping new approaches to early cancer detection and risk assessment, but also highlight the complexity of interpreting such results in healthy people Castro2018Ranade2020Mamis2026+2 MORE.
Sources and full results
Most relevant research papers on this topic